Volume 14, Issue 3 (May 2012) 14, 419–420; 10.1038/aja.2011.182
High-risk prostate cancer: is androgen deprivation monotherapy still appropriate?
Vahakn B Shahinian
Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109-2029, USA. vahakn@umich.edu
Correspondence: Dr VB Shahinian, (vahakn@umich.edu)
Abstract |
No abstract available
PDF |
PDF |
|
|
Browse: 3066 |
|